Madrigal Pharmaceuticals, Inc. financial data

Symbol
MDGL on Nasdaq
Location
200 Barr Harbor Drive, Suite 400, West Conshohocken, PA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 575 % -13.4%
Quick Ratio 22.7 %
Debt-to-equity 40.5 % -6.56%
Return On Equity -38.4 % +59.9%
Return On Assets -27.3 % +59%
Operating Margin -60.1 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 22.3M shares +2.65%
Common Stock, Shares, Outstanding 22.2M shares +11.8%
Entity Public Float 5.1B USD +61.5%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 22.2M shares +3.76%
Weighted Average Number of Shares Outstanding, Diluted 22.2M shares +3.76%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 137M USD
Revenue from Contract with Customer, Excluding Assessed Tax 516M USD +1354%
General and Administrative Expense 108M USD +125%
Operating Income (Loss) -310M USD +41.6%
Net Income (Loss) Attributable to Parent -282M USD +44.8%
Earnings Per Share, Basic -12 USD/shares +50.4%
Earnings Per Share, Diluted -12 USD/shares +50.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 186M USD -62.4%
Cash, Cash Equivalents, and Short-term Investments 802M USD -24.5%
Accounts Receivable, after Allowance for Credit Loss, Current 79.2M USD +1048%
Inventory, Net 63.5M USD +798%
Assets, Current 1B USD -8.1%
Property, Plant and Equipment, Net 1.62M USD -4.72%
Operating Lease, Right-of-Use Asset 5.86M USD +303%
Assets 1.02B USD -7.68%
Accounts Payable, Current 38M USD +322%
Employee-related Liabilities, Current 27.7M USD +29.8%
Accrued Liabilities, Current 157M USD +36.2%
Liabilities, Current 197M USD +57%
Operating Lease, Liability, Noncurrent 4.52M USD +403%
Liabilities 319M USD +31.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.11M USD
Retained Earnings (Accumulated Deficit) -1.92B USD -17.2%
Stockholders' Equity Attributable to Parent 696M USD -18.8%
Liabilities and Equity 1.02B USD -7.68%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -88.9M USD +40.4%
Net Cash Provided by (Used in) Financing Activities 8.64M USD -98.5%
Net Cash Provided by (Used in) Investing Activities 164M USD +67.1%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 22.2M shares +11.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 83.6M USD -84%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 191M USD -61.7%
Deferred Tax Assets, Valuation Allowance 509M USD +32.8%
Deferred Tax Assets, Gross 509M USD +32.8%
Operating Lease, Liability 2M USD +16.8%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -280M USD +45.1%
Lessee, Operating Lease, Liability, to be Paid 2.22M USD +19.4%
Operating Lease, Liability, Current 1.05M USD +88.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.07M USD +124%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.15M USD +22.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 221K USD +49.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 446K USD
Deferred Tax Assets, Operating Loss Carryforwards 214M USD +76.4%
Preferred Stock, Shares Issued 2.37M shares 0%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Preferred Stock, Shares Outstanding 2.37M shares 0%
Depreciation, Depletion and Amortization 379K USD +126%
Deferred Tax Assets, Net of Valuation Allowance 217K USD +85.5%
Share-based Payment Arrangement, Expense 81.7M USD +13.7%
Interest Expense 3.3M USD -14.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%